{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Turing Pharmaceuticals head Martin Shkreli acquires majority of shares of KaloBios Pharmaceuticals; shares soar more than 800 percent on news. ", "type_of_material": "News", "word_count": "397", "lead_paragraph": "Martin Shkreli, known for having raised the price an old drug fiftyfold, has bought more than half of KaloBios\u2019s outstanding shares.", "pub_date": "2015-11-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Group Led by Turing Chief Acquires Majority of Biotech Firm", "print_headline": "Shkreli Leads Bid for Biotech Firm"}, "snippet": "Martin Shkreli, known for having raised the price an old drug fiftyfold, has bought more than half of KaloBios\u2019s outstanding shares.", "multimedia": [{"height": 126, "url": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 731, "url": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-articleLarge-v2.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "731", "xlarge": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-articleLarge-v2.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/09/23/business/23SHKRELI-copy/23SHKRELI-copy-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/19/business/group-led-by-turing-chief-acquires-majority-of-biotech-firm.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "KaloBios Pharmaceuticals Inc.", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}], "blog": [], "_id": "564d469c38f0d81eb3ced0de", "source": "The New York Times"}